Dear Colleagues,
The Duke-Industry Statistics Symposium (DISS2024) will be held in person on April 3–5, 2024 with the theme "Statistical Innovation for Next-Generation Pharmaceutical Development". The symposium will explore the forefront of statistical innovation in next-generation clinical research for pharmaceutical products. For information about the program schedule, including short courses, speakers, talk abstracts, poster submission, and registration, please visit the DISS2024 Website.
Two keynote presentations will feature the work of Dr. Peter Stein, the Director of FDA CDER's Office of New Drugs, on "Changes in the Drug Development and Regulatory Landscape: Evolutions and Revolutions" on April 4 and Dr. Venkat Sethuraman, the Sr Vice President of Global Biometrics and Data Sciences of Bristol Myers Squibb, on "The Power of AI, Data Sciences, and Technology in Drug Development" on April 5.
Five short courses will be offered on April 3 with titles including AI/ML for Clinical Trials and Humanized AI for Future Healthcare, Dose Optimization, Pragmatic Benefit/Risk Evaluation, Adaptive Platform Trials, and Evaluation of Surrogate Endpoints in Oncology. Seventeen parallel sessions with invited speakers from industry, regulatory agencies, and academics will be offered with topics on Use of RWD to Generate RWE, Joint Modeling of Longitudinal Endpoints, Estimands for Clinical Trial, Bayesian Methods to Borrow Information in Rare Disease Trials, Optimizing Dosing in Drug Development, Covariate Adjustment in Randomized Clinical Trials, Multiple and Hierarchical Outcomes in Clinical Trials, Causal Inference Methods to Estimate Treatment Effects in Clinical Trials, Statistical Innovation in ctDNA Applications in Oncology Drug Development, Bridging Early Insights for Enhanced Oncology Decision-Making, Statistical and Regulatory Consideration for Rare Disease Drugs' Approval, and Statistical Innovation in Biosimilar and Bioequivalence Studies.
The symposium will offer significantly discounted registration fee for undergraduate and graduate students and postdoctoral scholars with majors in statistics, biostatistics, and data sciences. Students and postdoctoral scholars should email Judy Adkins at judy.adkins@duke.edu and Claire Zhang at yinuo.zhang@duke.edu with their valid credentials to request a student promo code.
We cordially invite submissions for poster presentations, the poster lightning talk session, and the poster award competition. The poster session and the poster lightning talk session offer a great opportunity for graduate students or junior researchers to share their research work. Posters may focus on any topic within quantitative methods used in pharmaceutical development. The symposium registration fee will be waived for all poster session participants. The deadline for consideration for the poster lightning talk session and the poster award competition is February 15. For more details regarding the poster sessions, please visit https://sites.duke.edu/diss/poster-session-2024/ and contact Dr. Hwanhee Hong at Hwanhee.Hong@duke.edu if you have any questions.
The Duke-Industry Statistics Symposium is organized by the Department of Biostatistics and Bioinformatics, Duke University School of Medicine together with industry and non-profit partners. This symposium series was established ten years ago to discuss challenging issues and recent advances related to the clinical development of drugs, biologics, and devices and to promote research and collaboration among statisticians from industry, academia, and regulatory agencies. We are excited to offer DISS2024 and look forward to seeing you in person on April 3-5 in Durham, North Carolina.
Sincerely yours,
The Organizing Committee of DISS2024
------------------------------
Xiaofei Wang
Duke University Medical Center
------------------------------